LESLIE MELTZER

Insider Reports History

Location
Waltham, MA
Signature
/s/ David Watson, attorney-in-fact for Leslie Meltzer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by LESLIE MELTZER:

Company Role Class Num Shares Value Price $ Report Date Ownership
Apellis Pharmaceuticals, Inc. Chief Research and Development Common Stock 107,024 $2,688,453 $25.12 28 Jan 2026 Direct
Apellis Pharmaceuticals, Inc. Chief Research and Development Stock Option (Right to Buy) 92,592 26 Aug 2025 Direct

Insider Reports Filed by LESLIE MELTZER

Symbol Company Period Transactions Value $ Form Type Role Filing Time
APLS Apellis Pharmaceuticals, Inc. 28 Jan 2026 1 $0 4 Chief Research and Development 30 Jan 2026, 16:09
APLS Apellis Pharmaceuticals, Inc. 26 Aug 2025 2 $0 4 Chief Research and Development 02 Sep 2025, 10:13
APLS Apellis Pharmaceuticals, Inc. 26 Aug 2025 0 $0 3 Chief Research and Development 02 Sep 2025, 10:12